Campbell & Co. Investment Adviser »

Haemonetics Corporation shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Haemonetics Corporation (HAE) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Haemonetics Corporation

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corporation held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corporation by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.3M 16k 85.35
2023-06-30 $533k 6.3k 85.14
2023-03-31 $1.5M 18k 82.75
2022-12-31 $1.1M 14k 78.65
2022-06-30 $212k 3.2k 65.29
2019-12-31 $276k 2.4k 114.86
2019-09-30 $337k 2.7k 126.31

More positions owned by Campbell & Co. Investment Adviser

United Rentals Common Stock (URI)
Parker-Hannifin Corp Common Stock (PH)
TE Connectivity Common Stock (TEL)
Nov Common Stock (NOV)
Revvity Common Stock (RVTY)
DuPont de Nemours Common Stock (DD)
Credit Acceptance Corp Common Stock (CACC)
State Street Corp Common Stock (STT)
Franklin Resources Common Stock (BEN)
Chubb Common Stock (CB)
McKesson Corp Common Stock (MCK)
Cheniere Energy Common Stock (LNG)
Idacorp Common Stock (IDA)
Jack Henry & Associates Common Stock (JKHY)
Nordson Corp Common Stock (NDSN)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Haemonetics Corporation

BlackRock
Vanguard Group
Neuberger Berman Group
Wellington Management Company
Franklin Resources
Royce & Associates
T. Rowe Price Investment Management
Geode Capital Management
Dimensional Fund Advisors
Btim
Westfield Capital Management Company
Fisher Investments
Northern Trust
T. Rowe Price Associates
Charles Schwab Investment Management

View all funds holding Haemonetics Corporation